Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.1164
- TODAY'S CHANGE (%)0.0264 (2.4220%)
- Bid / Lots1.1000/ 12
- Ask / Lots1.1200/ 15
- Open / Previous Close1.0900 / 1.0900
- Day Range
- 52 Week Range
- Volume10,916
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 1497 | 1.09 |
| 09:34 ET | 136 | 1.0962 |
| 10:06 ET | 1300 | 1.1 |
| 10:08 ET | 100 | 1.1 |
| 10:17 ET | 550 | 1.1 |
| 10:28 ET | 200 | 1.1 |
| 10:33 ET | 1000 | 1.1 |
| 10:39 ET | 3569 | 1.11 |
| 11:06 ET | 430 | 1.1017 |
| 11:33 ET | 300 | 1.12 |
| 11:51 ET | 438 | 1.1164 |
May 11, 2023
BRIEF-Co-Diagnostics Inc Reports First Quarter 2023 Financial Results, from 4:10PM ET on Thursday May 11, 2023 by Thomson Reuters
4:10PM ET on Thursday May 11, 2023 by Thomson Reuters-- Earnings Flash (CODX) CO-DIAGNOSTICS Posts Q1 Revenue $600,000, from 4:01PM ET on Thursday May 11, 2023 by MT Newswires
4:01PM ET on Thursday May 11, 2023 by MT NewswiresCo-Diagnostics, Inc. Reports First Quarter 2023 Financial Results, from 4:01PM ET on Thursday May 11, 2023 by PR Newswire
4:01PM ET on Thursday May 11, 2023 by PR Newswire
May 9, 2023
Co-Diagnostics, Inc. to Host Booth at Senior Living Executive Conference in New Orleans, LA, from 9:30AM ET on Tuesday May 09, 2023 by PR Newswire
9:30AM ET on Tuesday May 09, 2023 by PR Newswire
May 5, 2023
Co-Diagnostics, Inc. Announces First Quarter 2023 Earnings Release Date and Webcast, from 10:35AM ET on Friday May 05, 2023 by PR Newswire
10:35AM ET on Friday May 05, 2023 by PR Newswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 33.0M | -1.1x | --- |
LENSAR Inc | 32.6M | -1.9x | --- |
STRATA Skin Sciences Inc | 31.2M | -5.8x | --- |
ICAD Inc | 32.8M | -2.3x | --- |
Aamaxan Transport Group Inc | 20.0 | 0.0x | --- |
Telesis Bio Inc | 47.5M | -1.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and selling reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, including molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. It also uses its technology to design specific tests for its Co-Dx PCR Home platform and to locate genetic markers for use in applications other than infectious disease. It also sells diagnostic equipment from other manufacturers as self-contained lab systems. The Company is also developing a portable polymerase chain reaction (PCR) device and test cups that are designed to bring PCR to patients in point-of-care and even at-home settings. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer
- Dwight Egan
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Scientific Officer
- Mark Poritz
- Independent Director
- Eugene Durenard
- Independent Director
- Edward Murphy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.0M |
|---|---|
Revenue (TTM) | $12.1M |
Shares Outstanding | 30.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.65 |
EPS | $-1.06 |
Book Value | $3.71 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 2.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -339.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
